152 related articles for article (PubMed ID: 25728432)
1. A new gene for Parkinson's disease: should we care?
Singleton A
Lancet Neurol; 2015 Mar; 14(3):238-9. PubMed ID: 25728432
[No Abstract] [Full Text] [Related]
2. CHCHD2 and Parkinson's disease.
Foo JN; Liu J; Tan EK
Lancet Neurol; 2015 Jul; 14(7):681-2. PubMed ID: 26067114
[No Abstract] [Full Text] [Related]
3. CHCHD2 and Parkinson's disease.
Iqbal Z; Toft M
Lancet Neurol; 2015 Jul; 14(7):680-1. PubMed ID: 26067113
[No Abstract] [Full Text] [Related]
4. CHCHD2 and Parkinson's disease.
Liu G; Li K
Lancet Neurol; 2015 Jul; 14(7):679-80. PubMed ID: 26067112
[No Abstract] [Full Text] [Related]
5. CHCHD2 and Parkinson's disease.
Puschmann A; Dickson DW; Englund E; Wszolek ZK; Ross OA
Lancet Neurol; 2015 Jul; 14(7):679. PubMed ID: 26067111
[No Abstract] [Full Text] [Related]
6. CHCHD2 and Parkinson's disease--authors' reply.
Funayama M; Hattori N
Lancet Neurol; 2015 Jul; 14(7):682-3. PubMed ID: 26067115
[No Abstract] [Full Text] [Related]
7. CHCHD2 and Parkinson's disease.
Jansen IE; Bras JM; Lesage S; Schulte C; Gibbs JR; Nalls MA; Brice A; Wood NW; Morris H; Hardy JA; Singleton AB; Gasser T; Heutink P; Sharma M;
Lancet Neurol; 2015 Jul; 14(7):678-9. PubMed ID: 26067110
[No Abstract] [Full Text] [Related]
8. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
[TBL] [Abstract][Full Text] [Related]
9. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A
Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of CHCHD2 in a southern Spanish population.
Tejera-Parrado C; Jesús S; Huertas-Fernández I; Bernal-Bernal I; Bonilla-Toribio M; Córdoba-Tevar I; Abreu-Rodríguez I; Carrillo F; Bernal-Escudero M; Vargas-González L; Carballo M; Gómez-Garre P; Mir P
Neurobiol Aging; 2017 Feb; 50():169.e1-169.e2. PubMed ID: 27839904
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.
Jasinska-Myga B; Kachergus J; Vilariño-Güell C; Wider C; Soto-Ortolaza AI; Kefi M; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Yahmed SB; Sassi SB; Zouari M; El Euch G; Ross OA; Hentati F; Farrer MJ
Mov Disord; 2010 Oct; 25(13):2052-8. PubMed ID: 20721913
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Nurr1 nucleotide variations in familial Parkinson's disease.
Levecque C; Destée A; Mouroux V; Amouyel P; Chartier-Harlin MC
Neurosci Lett; 2004 Aug; 366(2):135-8. PubMed ID: 15276233
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.
Alvarez V; Corao AI; Sánchez-Ferrero E; De Mena L; Alonso-Montes C; Huerta C; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; García-Castro M; Coto E
Neurosci Lett; 2008 Feb; 432(1):79-82. PubMed ID: 18248889
[TBL] [Abstract][Full Text] [Related]
14. NR4A2 mutations are rare among European patients with familial Parkinson's disease.
Wellenbrock C; Hedrich K; Schäfer N; Kasten M; Jacobs H; Schwinger E; Hagenah J; Pramstaller PP; Vieregge P; Klein C
Ann Neurol; 2003 Sep; 54(3):415. PubMed ID: 12953278
[No Abstract] [Full Text] [Related]
15. Alzheimer's disease and Parkinson's disease.
Nussbaum RL; Ellis CE
N Engl J Med; 2003 Apr; 348(14):1356-64. PubMed ID: 12672864
[No Abstract] [Full Text] [Related]
16. Autosomal dominant Parkinson's disease caused by SNCA duplications.
Konno T; Ross OA; Puschmann A; Dickson DW; Wszolek ZK
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S1-6. PubMed ID: 26350119
[TBL] [Abstract][Full Text] [Related]
17. DNAJC13 genetic variants in parkinsonism.
Gustavsson EK; Trinh J; Guella I; Vilariño-Güell C; Appel-Cresswell S; Stoessl AJ; Tsui JK; McKeown M; Rajput A; Rajput AH; Aasly JO; Farrer MJ
Mov Disord; 2015 Feb; 30(2):273-8. PubMed ID: 25393719
[TBL] [Abstract][Full Text] [Related]
18. Predicted pathogenic missense mutation of PGRN found in a normal control.
Kim HJ; Seong MW; Yun JY; Park SS; Lee JY; Jeon BS
Ann Neurol; 2010 Mar; 67(3):415-6. PubMed ID: 20373362
[No Abstract] [Full Text] [Related]
19. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.
Zhang M; Xi Z; Fang S; Ghani M; Sato C; Moreno D; Liang Y; Lang AE; Rogaeva E
Neurobiol Aging; 2016 Feb; 38():217.e7-217.e8. PubMed ID: 26639156
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of pathogenesis of Parkinson's disease.
Shadrina MI; Slominsky PA; Limborska SA
Int Rev Cell Mol Biol; 2010; 281():229-66. PubMed ID: 20460187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
